Details of the Drug
General Information of Drug (ID: DM4Z56O)
Drug Name |
2-nitro-N-(quinolin-8-yl)benzenesulfonamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
MLS001123640; SMR000658615; 2-nitro-N-quinolin-8-ylbenzenesulfonamide; 2-Nitro-N-quinolin-8-yl-benzenesulfonamide; AC1LEORR; CBKinase1_000077; CBKinase1_012477; Cambridge id 5175135; Oprea1_237550; CBDivE_007245; cid_739449; CHEMBL270605; SCHEMBL11973295; BDBM60287; MolPort-002-134-446; YCXUFEOBLVZNAP-UHFFFAOYSA-N; ZINC175212; AKOS033118464; MCULE-3457699063; NCGC00161682-02; NCGC00161682-01; NCGC00161682-03; 2-nitro-N-(8-quinolyl)benzenesulfonamide; N-(8-Quinolyl)-2-nitrobenzenesulfonamide
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 329.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 6 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||